• Antiresistance AR Antagonists for Prostate Cancer

  2026-09-16

  The reference study identifies a new strategy for overcoming androgen receptor resistance by targeting the receptor dimer interface rather than the mutation-prone ligand-binding pocket. Through optimization of the M17-B15 series, the authors discovered Y5, a compound that combines AR dimerization disruption with ubiquitin–proteasome-dependent AR degradation and suppresses LNCaP xenograft growth after oral administration.

• A-1210477 MCL-1 Inhibitor Workflow

  2026-09-16

  Build a mechanism-first in vitro workflow around A-1210477 to distinguish MCL-1-dependent survival from nonspecific cytotoxicity. The guide combines dose-response, mitochondrial apoptosis, BAX/BAK-informed validation, and combination testing with practical handling and troubleshooting advice.

• Ibotenic Acid Toxicity in Mice: Dose and Time

  2026-09-15

  A 2026 study in mice provides an integrated analysis of ibotenic acid toxicity across behavior, blood biochemistry, histopathology, and immunohistochemistry. Its findings distinguish transient abnormalities at 16 mg/kg from severe, potentially fatal toxicity at 33 mg/kg and identify early c-fos activation and reduced Nissl bodies as useful indicators of neural injury.

• Ibotenic Acid: From Toxicity to Assay Design

  2026-09-15

  Ibotenic acid is an NMDA receptor agonist with value beyond disease modeling. This guide translates dose- and time-dependent mouse toxicity findings into practical assay-design, formulation, storage, and interpretation decisions.

• Pemetrexed: A DNA-Repair-Aware Research Framework

  2026-09-14

  Pemetrexed research is most informative when antifolate stress is interpreted alongside DNA-repair phenotype. This guide connects pemetrexed disodium mechanism, malignant mesothelioma models, and assay design using findings from a landmark homologous-recombination study.

• Pam3CSK4 TFA for TLR1/2 Immune Profiling

  2026-09-14

  Pam3CSK4 TFA provides a defined way to model TLR1/2-driven innate immune activation in cell assays and translational inflammation studies. This workflow connects controlled receptor stimulation with cytokine profiling, including IL-17A-focused investigations inspired by maternal–neonatal Group B Streptococcus research.

• PKH26 Red Fluorescent Cell Linker Kit Guide

  2026-09-13

  The PKH26 Red Fluorescent Cell Linker Kit provides membrane-specific red fluorescence for tracing labeled cells and evaluating proliferation over extended experiments. It is intended for cell membrane lipid-region labeling in vitro or in vivo, not for intracellular targets or non-membrane structures.

• Recombinant Mouse Sonic Hedgehog Workflow Guide

  2026-09-12

  A practical guide to using Recombinant Mouse Sonic Hedgehog in cell-based assays, organ cultures, and comparative developmental models. Learn how to connect alkaline phosphatase induction with tissue-level readouts while avoiding common dose, storage, and cross-species interpretation errors.

• JNK-IN-7 for Apoptosis Pathway Dissection

  2026-09-12

  JNK-IN-7 is a selective JNK inhibitor for separating c-Jun–linked MAPK activity from broader inflammatory and apoptotic responses. This practical guide adapts findings from Candida krusei–challenged bovine mammary epithelial cells into a controlled workflow for phosphorylation, innate immune signaling, and apoptosis assays.

• AIBP-LRP2 Axis Restricts Collateral Vessel Growth

  2026-09-11

  A 2025 Science Advances study identifies an AIBP–LRP2–HDL–miR-223 pathway that limits CXCR4-positive, stemlike capillary endothelial cell expansion during ischemic vascular remodeling. The work supports a two-phase model in which CXCR4-dependent capillary growth precedes arterial conversion, offering a mechanistic framework for improving collateral circulation in peripheral artery disease.

• Live-Dead Bacterial Staining Kit for Nanomaterial Assays

  2026-09-11

  Pair membrane-integrity staining with pH, nanoparticle, and magnetic-field controls to test antibacterial materials more rigorously. The Live-Dead Bacterial Staining Kit provides a practical fluorescence readout for distinguishing total bacterial burden from membrane-compromised cells, while orthogonal validation helps prevent overinterpreting dye signals.

• Budesonide in Reliable Cell Assays

  2026-09-10

  This scenario-driven guide shows how Budesonide, SKU B1900, can support more interpretable viability, proliferation, and airway inflammation experiments. It connects formulation control, exposure modeling, vehicle matching, and vendor selection with evidence from a recent pulmonary permeability study.

• From Mechanism to Signal: Smarter ECL Translation

  2026-09-10

  Translational protein biology depends on more than discovering a pathway: researchers must convert mechanistic hypotheses into reproducible, decision-ready measurements. This article connects the TLR4/NF-κB findings of a Sanghuangporus vaninii hetero-galactan study with practical strategy for sensitive immunoblotting and low-abundance protein validation.

• AIBP-LRP2–HDL Axis in Collateral Circulation

  2026-09-09

  Zhu et al. identify an AIBP-LRP2–HDL–miR-223 pathway that restrains CXCR4+ stemlike capillary endothelial cells during collateral vessel formation. The study links lipid handling to a two-phase remodeling program in which capillary cells expand before adopting arterial characteristics, offering a mechanistic framework for ischemic revascularization research.

• SR 11302 AP-1 Inhibitor: Cancer Assay Workflows

  2026-09-09

  SR 11302 provides a retinoid-independent route to suppress AP-1 signaling in tumor-cell and tumor-microenvironment studies. This practical guide connects dose-controlled proliferation assays with macrophage-polarization workflows inspired by recent colitis-associated colorectal cancer research.

8558 records 1/571 page Next 12345 下5页 Last page